Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear envelope pore membrane protein POM 121B (POM121B) is an integral transmembrane protein and a structural component of the nuclear pore complex (NPC), mediating nuclear-cytoplasmic transport by anchoring key nucleoporin subcomplexes to the nuclear envelope[1][2][3][4][5]. POM121B possesses an N-terminal membrane-spanning domain, nuclear localization signals that facilitate nuclear targeting through importin-α/β, and C-terminal FG repeats that assist in molecular trafficking across the NPC[4][5]. It is indispensable for NPC assembly during interphase and interacts with scaffold NPC proteins such as Nup155 and Nup160[2][3]. POM121B has been implicated in cancer, both as a gene fusion partner and by mediating oncogenic transport into the nucleus[1]. Though not a therapeutic target in the conventional sense (e.g., receptor or enzyme), its role is essential for nuclear architecture and cell viability[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear envelope pore membrane protein POM 121B (POM121B).